Skip to main content

Table 2 Survival rate after neoadjuvant chemotherapy for advanced adenocarcinoma

From: The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract

Study

Adeno-carcinoma n (%)

Survival CHX + Surgery

Survival Surgery

p- value

MRC, 2002 [9]

528 (66%)

32%

25%

0.02

  

(3 y)

(3 y)

 

MAGIC, 2006 [10]

503 (100% dist.

36.3%

23%

0.009

 

esophagus and stomach)

(5 y)

(5 y)

 

FFCD, 2007 [11]

226 (100% dist.

38%

24%

0.021

 

esophagus and stomach)

(5 y)

(5 y)

 
  1. CHX = chemotherapy, y = years